Why Coherus BioSciences Stock Jumped Today

Shares of Coherus BioSciences (CHRS 14.85%) climbed 14.9% on Tuesday after the company announced a positive revision to the terms of its loan agreement with Pharmakon Advisors.On the positive fallout of Coherus' recent divestmentIn a press release late yesterday, Coherus announced it has entered into an agreement with Pharmakon Advisors to revise the terms of its loan agreement entered in January 2022. After Coherus closes the previously announced divestiture of its noncore ophthalmology business to Sandoz ...